Table 1 Key baseline characteristics of the study population

Group, n (%)

<0.001^a

<0.001^a

<0.001^a

Conventional Outpatient Follow-up

11,217 (83.3%)

1017 (19.7%)

759 (13.8%)

Digital Health Management Follow-up

2256 (16.7%)

4156 (80.3%)

4724 (86.2%)

Sex, Male, n (%)

9381 (69.6%)

3501 (67.7%)

3522 (64.2%)

<0.001^a

0.010^a

<0.001^a

Age, Median (IQR)

64 (55, 72)

61 (55, 71)

62 (55, 71)

<0.001^b

<0.001^c

0.2^c

Age > 65 years, n (%)

6099 (45.3%)

1941 (37.5%)

2024 (36.9%)

<0.001^a

<0.001^a

0.5^a

Current smoking, n (%)

5553 (41.3%)

1960 (38.0%)

1853 (33.8%)

<0.001^a

<0.001^a

<0.001^a

Current drinking, n (%)

6174 (45.9%)

2139 (41.5%)

1633 (29.8%)

<0.001^a

<0.001^a

<0.001^a

Acute coronary syndrome, n (%)

11,850 (88.0%)

4239 (82.0%)

3990 (72.8%)

<0.001^a

<0.001^a

<0.001^a

Hypertension, n (%)

9284 (68.9%)

3515 (67.9%)

3691 (67.3%)

0.081^a

0.2^a

0.5^a

Hyperlipidemia, n (%)

7026 (52.1%)

2843 (55.0%)

2635 (48.1%)

<0.001^a

<0.001^a

<0.001^a

Diabetes mellitus, n (%)

8238 (61.1%)

2756 (53.3%)

2759 (50.3%)

<0.001^a

<0.001^a

0.002^a

Stroke, n (%)

1788 (13.3%)

657 (12.7%)

535 (9.8%)

<0.001^a

0.3^a

<0.001^a

Heart failure, n (%)

6134 (45.5%)

2532 (48.9%)

2619 (47.8%)

<0.001^a

<0.001^a

0.2^a

Chronic kidney disease, n (%)

4765 (35.4%)

1593 (30.8%)

1169 (21.3%)

<0.001^a

<0.001^a

<0.001^a

EF, Median (IQR)

55 (46, 65)

55 (44, 65)

56 (45, 65)

0.031^b

0.014^c

0.023^c

LDL-C, Median (IQR)

2.63 (1.58, 4.00)

2.94 (1.99, 3.75)

2.89 (2.25, 3.41)

<0.001^b

<0.001^c

<0.001^c

eGFR, Median (IQR)

76 (55, 98)

75 (57, 95)

75 (63, 89)

0.9^b

0.7^c

0.8^c

Multi-vessel disease, n (%)

4964 (36.8%)

2530 (48.9%)

4275 (78.0%)

<0.001^a

<0.001^a

<0.001^a

PCI, n (%)

7867 (58.4%)

3294 (63.7%)

4325 (78.9%)

<0.001^a

<0.001^a

<0.001^a